Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
-
CLINICAL_TRIALS study record update · 2025-04-27mUlticenter, Single-arM, Open-laBel, Long-teRm Safety Study With macitEntan in Patients With puLmonary Arterial Hypertension previousLy Treated With mAcitentan in Clinical Studies
-
CLINICAL_TRIALS study record update · 2025-04-08Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2025-04-02Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2025-03-30Open-Label, Randomized Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Different Formulations of an IP Receptor Agonist
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-30Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
-
CLINICAL_TRIALS study record update · 2025-03-30Heart Rate Variability (HRV) as a Marker of Treatment Response in Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2025-03-30US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice
-
CLINICAL_TRIALS study record update · 2025-03-30An Extension of AC-055-310, a Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™
-
CLINICAL_TRIALS study record update · 2025-03-30Uptravi® (SelexiPag): tHe usErs dRug rEgistry
-
CLINICAL_TRIALS study record update · 2025-03-28Prospective, Monocentric Pilot Study for the Identification of Known or Novel Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
-
CLINICAL_TRIALS study record update · 2025-03-26Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
-
CLINICAL_TRIALS study record update · 2025-03-25Exercise Capacity Respiratory Muscle Strength Pulmonary Function Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2025-03-25Repurposing Valsartan May Protect Against Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2025-03-19A Bridged Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Dose of MN-08 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-03-13Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
-
CLINICAL_TRIALS study record update · 2025-03-12Efficacy of Triple-Combination Therapy in Severe Pulmonary Arterial Hypertension Associated Congenital Heart Diseases
-
CLINICAL_TRIALS study record update · 2025-03-124DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease
-
CLINICAL_TRIALS study record update · 2025-02-27A Phase 3 Non-randomized, Non-controlled, Open Label Clinical Study to Evaluate the Efficacy and Safety of MK-7962 (Sotatercept) add-on to Background Therapy in Japanese Participants With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2025-02-21A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2025-02-20A Prospective Trial to Evaluate Up-front Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Patients With Advanced Pulmonary Arterial Hypertension (IIR-3810)
-
CLINICAL_TRIALS study record update · 2025-02-13Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2025-02-12Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-02-10RiOciguAt UseRs Registry
-
CLINICAL_TRIALS study record update · 2025-02-03Adult Congenital Heart Disease Quality Enhancement Research Initiative